Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
PHOX2B sequencing of the entire coding sequence and splice sites Molecular Diagnostics Ann and Robert H. Lurie Children's Hospital of Chicago United States | 1 | 1 |
|
Tempus AI - RTP United States | 2 | 647 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
DNA Labs India India | 1 | 1 |
|
Hereditary Endocrine Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 24 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Tempus AI - CHI United States | 2 | 647 |
|
PHOX2B deletion/duplication testing Molecular Diagnostics Ann and Robert H. Lurie Children's Hospital of Chicago United States | 1 | 1 |
|
OncoAlly™ Comprehensive Hereditary Cancer Analysis Variantyx, Inc. United States | 1 | 88 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
PHOX2B - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 99 | 101 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
PathGroup United States | 73 | 505 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.